Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Radiation Dose Management Market by Component (Sloution, Software), by Mobility (Computed Tomography, Fluoroscopy Interventional Imaging, Radiography Mammography, Nuclear Medicine), by Application (Oncology, Cardiology, Orthopedic Applications, Other) and by End User (Hospitals, Small Hospitals, Large Hospitals, Ambulatory Care Settings, Other): Global Opportunity Analysis and Industry Forecast, 2023-2032

A00791

Pages: NA

Charts: NA

Tables: NA

A standard that provides healthcare experts an additional equipment to optimize and regulate dose in computerized axial tomography scan (or CT scan) etc. is generally termed as radiation dose management. The radiation management solution plays a vital role in lowering patient exposure to harmful radiation dose undergoing imaging procedures. Furthermore, such measures enable patients to receive medical benefits of X-ray technology, CT scan and more, while reducing the risks associated with the dose.

The radiation dose management market is influenced by several drivers, restraints and opportunities. Growing requirement for patient safety, strict federal and state regulations and obligations laid down for the healthcare provides, has played a vital role in the growth of the industry. However, absence of standard protocols and insufficient funding in the radiation dose management has hampered the growth of the market of a greater extent. On the other hand, regions such as North America would create greater opportunities for the market.

The market is segmented based on products, application, end-customer and geography. The products covered in the market research report consists of software, services, consulting services and more. The applications discussed in the report include Radiography, Mammography etc. Major end-customers served by the industry includes hospitals, clinics, research centers and more. Regions including North America, Europe, Asia -Pacific and LAMEA would experience tremendous growth

A closer look at the competitive landscape reveals that major IT brands are busy launching radiation dose management solutions and generating clients in the same month itself. Prominent market players are also seen acquiring new companies or local market players to maintain their competitive edge. Other business strategies favored by the companies include constant upgradation, joint ventures and collaborations. Prominent brands active in the market Fujifilm Holdings Corporation, Bayer AG, Sectra Medical Systems, PACSHealth LLC, Novarad Corporation and many others

KEY BENEFITS FOR STAKEHOLDERS

  • The market research report provides an integrated information on the major drivers, restraints and opportunities influencing the industry growth, during the forecast.
  • The study further drills down to produce data volume by components, end customers and demography.
  • SWOT analysis of major brands, highlights weaknesses, strengths, opportunities and threats. The data proves effective for business owners planning on designing their marketing and branding strategies.
  • Region wise business performance discussed in the market research report would be valuable for enterprises planning to explore new areas.
  • The report not only examines the market dynamics but also takes a closer look at the growth rate and industrial chain structure.
  • Study further weigh up on the prominent market players and what they are doing different to position their product in the already crowded marketplace.
  • Assessment of upstream and downstream market also forms an important part of the report.

Key Market Segments

  • By Component
    • Sloution
    • Software
  • By Mobility
    • Computed Tomography
    • Fluoroscopy & Interventional Imaging
    • Radiography & Mammography
    • Nuclear Medicine
  • By Application
    • Oncology
    • Cardiology
    • Orthopedic Applications
    • Other
  • By End User
    • Hospitals
    • Small Hospitals
    • Large Hospitals
    • Ambulatory Care Settings
    • Other
  • By Region
    • North America
      • U.S.
      • Canada
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Latin America
      • Middle East
      • Africa


Key Market Players

  • PACSHealth, LLC
  • Bracco Imaging S.p.A.
  • GE Healthcare
  • FUJIFILM Holdings Corporation
  • Bayer AG
  • Agfa Healthcare
  • Philips Healthcare
  • Sectra AB
  • Qaelum N.V.
  • Canon Inc.
  • Siemens Healthineers
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: RADIATION DOSE MANAGEMENT MARKET, BY COMPONENT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Component

    • 4.2. Sloution

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Software

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: RADIATION DOSE MANAGEMENT MARKET, BY MOBILITY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Mobility

    • 5.2. Computed Tomography

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Fluoroscopy And Interventional Imaging

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Radiography And Mammography

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Nuclear Medicine

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. Oncology

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Cardiology

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Orthopedic Applications

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Other

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: RADIATION DOSE MANAGEMENT MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Hospitals

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Small Hospitals

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Large Hospitals

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Ambulatory Care Settings

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

    • 7.6. Other

      • 7.6.1. Key Market Trends, Growth Factors and Opportunities

      • 7.6.2. Market Size and Forecast, By Region

      • 7.6.3. Market Share Analysis, By Country

  • CHAPTER 8: RADIATION DOSE MANAGEMENT MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Component

      • 8.2.3. Market Size and Forecast, By Mobility

      • 8.2.4. Market Size and Forecast, By Application

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Radiation Dose Management Market

        • 8.2.7.1. Market Size and Forecast, By Component
        • 8.2.7.2. Market Size and Forecast, By Mobility
        • 8.2.7.3. Market Size and Forecast, By Application
        • 8.2.7.4. Market Size and Forecast, By End User
      • 8.2.8. Canada Radiation Dose Management Market

        • 8.2.8.1. Market Size and Forecast, By Component
        • 8.2.8.2. Market Size and Forecast, By Mobility
        • 8.2.8.3. Market Size and Forecast, By Application
        • 8.2.8.4. Market Size and Forecast, By End User
      • 8.2.9. Mexico Radiation Dose Management Market

        • 8.2.9.1. Market Size and Forecast, By Component
        • 8.2.9.2. Market Size and Forecast, By Mobility
        • 8.2.9.3. Market Size and Forecast, By Application
        • 8.2.9.4. Market Size and Forecast, By End User
    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Component

      • 8.3.3. Market Size and Forecast, By Mobility

      • 8.3.4. Market Size and Forecast, By Application

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Radiation Dose Management Market

        • 8.3.7.1. Market Size and Forecast, By Component
        • 8.3.7.2. Market Size and Forecast, By Mobility
        • 8.3.7.3. Market Size and Forecast, By Application
        • 8.3.7.4. Market Size and Forecast, By End User
      • 8.3.8. Germany Radiation Dose Management Market

        • 8.3.8.1. Market Size and Forecast, By Component
        • 8.3.8.2. Market Size and Forecast, By Mobility
        • 8.3.8.3. Market Size and Forecast, By Application
        • 8.3.8.4. Market Size and Forecast, By End User
      • 8.3.9. Italy Radiation Dose Management Market

        • 8.3.9.1. Market Size and Forecast, By Component
        • 8.3.9.2. Market Size and Forecast, By Mobility
        • 8.3.9.3. Market Size and Forecast, By Application
        • 8.3.9.4. Market Size and Forecast, By End User
      • 8.3.10. Spain Radiation Dose Management Market

        • 8.3.10.1. Market Size and Forecast, By Component
        • 8.3.10.2. Market Size and Forecast, By Mobility
        • 8.3.10.3. Market Size and Forecast, By Application
        • 8.3.10.4. Market Size and Forecast, By End User
      • 8.3.11. UK Radiation Dose Management Market

        • 8.3.11.1. Market Size and Forecast, By Component
        • 8.3.11.2. Market Size and Forecast, By Mobility
        • 8.3.11.3. Market Size and Forecast, By Application
        • 8.3.11.4. Market Size and Forecast, By End User
      • 8.3.12. Russia Radiation Dose Management Market

        • 8.3.12.1. Market Size and Forecast, By Component
        • 8.3.12.2. Market Size and Forecast, By Mobility
        • 8.3.12.3. Market Size and Forecast, By Application
        • 8.3.12.4. Market Size and Forecast, By End User
      • 8.3.13. Rest Of Europe Radiation Dose Management Market

        • 8.3.13.1. Market Size and Forecast, By Component
        • 8.3.13.2. Market Size and Forecast, By Mobility
        • 8.3.13.3. Market Size and Forecast, By Application
        • 8.3.13.4. Market Size and Forecast, By End User
    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Component

      • 8.4.3. Market Size and Forecast, By Mobility

      • 8.4.4. Market Size and Forecast, By Application

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Radiation Dose Management Market

        • 8.4.7.1. Market Size and Forecast, By Component
        • 8.4.7.2. Market Size and Forecast, By Mobility
        • 8.4.7.3. Market Size and Forecast, By Application
        • 8.4.7.4. Market Size and Forecast, By End User
      • 8.4.8. Japan Radiation Dose Management Market

        • 8.4.8.1. Market Size and Forecast, By Component
        • 8.4.8.2. Market Size and Forecast, By Mobility
        • 8.4.8.3. Market Size and Forecast, By Application
        • 8.4.8.4. Market Size and Forecast, By End User
      • 8.4.9. India Radiation Dose Management Market

        • 8.4.9.1. Market Size and Forecast, By Component
        • 8.4.9.2. Market Size and Forecast, By Mobility
        • 8.4.9.3. Market Size and Forecast, By Application
        • 8.4.9.4. Market Size and Forecast, By End User
      • 8.4.10. South Korea Radiation Dose Management Market

        • 8.4.10.1. Market Size and Forecast, By Component
        • 8.4.10.2. Market Size and Forecast, By Mobility
        • 8.4.10.3. Market Size and Forecast, By Application
        • 8.4.10.4. Market Size and Forecast, By End User
      • 8.4.11. Australia Radiation Dose Management Market

        • 8.4.11.1. Market Size and Forecast, By Component
        • 8.4.11.2. Market Size and Forecast, By Mobility
        • 8.4.11.3. Market Size and Forecast, By Application
        • 8.4.11.4. Market Size and Forecast, By End User
      • 8.4.12. Thailand Radiation Dose Management Market

        • 8.4.12.1. Market Size and Forecast, By Component
        • 8.4.12.2. Market Size and Forecast, By Mobility
        • 8.4.12.3. Market Size and Forecast, By Application
        • 8.4.12.4. Market Size and Forecast, By End User
      • 8.4.13. Malaysia Radiation Dose Management Market

        • 8.4.13.1. Market Size and Forecast, By Component
        • 8.4.13.2. Market Size and Forecast, By Mobility
        • 8.4.13.3. Market Size and Forecast, By Application
        • 8.4.13.4. Market Size and Forecast, By End User
      • 8.4.14. Indonesia Radiation Dose Management Market

        • 8.4.14.1. Market Size and Forecast, By Component
        • 8.4.14.2. Market Size and Forecast, By Mobility
        • 8.4.14.3. Market Size and Forecast, By Application
        • 8.4.14.4. Market Size and Forecast, By End User
      • 8.4.15. Rest of Asia Pacific Radiation Dose Management Market

        • 8.4.15.1. Market Size and Forecast, By Component
        • 8.4.15.2. Market Size and Forecast, By Mobility
        • 8.4.15.3. Market Size and Forecast, By Application
        • 8.4.15.4. Market Size and Forecast, By End User
    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Component

      • 8.5.3. Market Size and Forecast, By Mobility

      • 8.5.4. Market Size and Forecast, By Application

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Radiation Dose Management Market

        • 8.5.7.1. Market Size and Forecast, By Component
        • 8.5.7.2. Market Size and Forecast, By Mobility
        • 8.5.7.3. Market Size and Forecast, By Application
        • 8.5.7.4. Market Size and Forecast, By End User
      • 8.5.8. South Africa Radiation Dose Management Market

        • 8.5.8.1. Market Size and Forecast, By Component
        • 8.5.8.2. Market Size and Forecast, By Mobility
        • 8.5.8.3. Market Size and Forecast, By Application
        • 8.5.8.4. Market Size and Forecast, By End User
      • 8.5.9. Saudi Arabia Radiation Dose Management Market

        • 8.5.9.1. Market Size and Forecast, By Component
        • 8.5.9.2. Market Size and Forecast, By Mobility
        • 8.5.9.3. Market Size and Forecast, By Application
        • 8.5.9.4. Market Size and Forecast, By End User
      • 8.5.10. UAE Radiation Dose Management Market

        • 8.5.10.1. Market Size and Forecast, By Component
        • 8.5.10.2. Market Size and Forecast, By Mobility
        • 8.5.10.3. Market Size and Forecast, By Application
        • 8.5.10.4. Market Size and Forecast, By End User
      • 8.5.11. Argentina Radiation Dose Management Market

        • 8.5.11.1. Market Size and Forecast, By Component
        • 8.5.11.2. Market Size and Forecast, By Mobility
        • 8.5.11.3. Market Size and Forecast, By Application
        • 8.5.11.4. Market Size and Forecast, By End User
      • 8.5.12. Rest of LAMEA Radiation Dose Management Market

        • 8.5.12.1. Market Size and Forecast, By Component
        • 8.5.12.2. Market Size and Forecast, By Mobility
        • 8.5.12.3. Market Size and Forecast, By Application
        • 8.5.12.4. Market Size and Forecast, By End User
  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning, 2024

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Bayer AG

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. GE Healthcare

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Philips Healthcare

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Siemens Healthineers

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. FUJIFILM Holdings Corporation

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Canon Inc.

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. PACSHealth, LLC

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Sectra AB

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Bracco Imaging S.p.A.

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. Qaelum N.V.

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

    • 10.11. Agfa Healthcare

      • 10.11.1. Company Overview

      • 10.11.2. Key Executives

      • 10.11.3. Company Snapshot

      • 10.11.4. Operating Business Segments

      • 10.11.5. Product Portfolio

      • 10.11.6. Business Performance

      • 10.11.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL RADIATION DOSE MANAGEMENT MARKET, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR SLOUTION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL RADIATION DOSE MANAGEMENT MARKET, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR FLUOROSCOPY AND INTERVENTIONAL IMAGING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR RADIOGRAPHY AND MAMMOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR ONCOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR CARDIOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR OTHER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR SMALL HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR LARGE HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. GLOBAL RADIATION DOSE MANAGEMENT MARKET FOR OTHER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. GLOBAL RADIATION DOSE MANAGEMENT MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. NORTH AMERICA RADIATION DOSE MANAGEMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 22. NORTH AMERICA RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 23. NORTH AMERICA RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 24. NORTH AMERICA RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. NORTH AMERICA RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 26. U.S. RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 27. U.S. RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 28. U.S. RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. U.S. RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. CANADA RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 31. CANADA RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 32. CANADA RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. CANADA RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. MEXICO RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 35. MEXICO RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 36. MEXICO RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 37. MEXICO RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 38. EUROPE RADIATION DOSE MANAGEMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 39. EUROPE RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 40. EUROPE RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 41. EUROPE RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. EUROPE RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. FRANCE RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 44. FRANCE RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 45. FRANCE RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. FRANCE RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 47. GERMANY RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 48. GERMANY RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 49. GERMANY RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. GERMANY RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. ITALY RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 52. ITALY RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 53. ITALY RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. ITALY RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. SPAIN RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 56. SPAIN RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 57. SPAIN RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. SPAIN RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. UK RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 60. UK RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 61. UK RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 62. UK RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. RUSSIA RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 64. RUSSIA RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 65. RUSSIA RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 66. RUSSIA RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. REST OF EUROPE RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 68. REST OF EUROPE RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 69. REST OF EUROPE RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. REST OF EUROPE RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. ASIA-PACIFIC RADIATION DOSE MANAGEMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 72. ASIA-PACIFIC RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 73. ASIA-PACIFIC RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 74. ASIA-PACIFIC RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 75. ASIA-PACIFIC RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 76. CHINA RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 77. CHINA RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 78. CHINA RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 79. CHINA RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 80. JAPAN RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 81. JAPAN RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 82. JAPAN RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 83. JAPAN RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 84. INDIA RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 85. INDIA RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 86. INDIA RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 87. INDIA RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 88. SOUTH KOREA RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 89. SOUTH KOREA RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 90. SOUTH KOREA RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 91. SOUTH KOREA RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 92. AUSTRALIA RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 93. AUSTRALIA RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 94. AUSTRALIA RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 95. AUSTRALIA RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 96. THAILAND RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 97. THAILAND RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 98. THAILAND RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 99. THAILAND RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 100. MALAYSIA RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 101. MALAYSIA RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 102. MALAYSIA RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 103. MALAYSIA RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 104. INDONESIA RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 105. INDONESIA RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 106. INDONESIA RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 107. INDONESIA RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 108. REST OF ASIA PACIFIC RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 109. REST OF ASIA PACIFIC RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 110. REST OF ASIA PACIFIC RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 111. REST OF ASIA PACIFIC RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 112. LAMEA RADIATION DOSE MANAGEMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 113. LAMEA RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 114. LAMEA RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 115. LAMEA RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 116. LAMEA RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 117. BRAZIL RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 118. BRAZIL RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 119. BRAZIL RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 120. BRAZIL RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 121. SOUTH AFRICA RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 122. SOUTH AFRICA RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 123. SOUTH AFRICA RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 124. SOUTH AFRICA RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 125. SAUDI ARABIA RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 126. SAUDI ARABIA RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 127. SAUDI ARABIA RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 128. SAUDI ARABIA RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 129. UAE RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 130. UAE RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 131. UAE RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 132. UAE RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 133. ARGENTINA RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 134. ARGENTINA RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 135. ARGENTINA RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 136. ARGENTINA RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 137. REST OF LAMEA RADIATION DOSE MANAGEMENT, BY COMPONENT, 2025-2033 ($MILLION)
  • TABLE 138. REST OF LAMEA RADIATION DOSE MANAGEMENT, BY MOBILITY, 2025-2033 ($MILLION)
  • TABLE 139. REST OF LAMEA RADIATION DOSE MANAGEMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 140. REST OF LAMEA RADIATION DOSE MANAGEMENT, BY END USER, 2025-2033 ($MILLION)
  • TABLE 141. BAYER AG: KEY EXECUTIVES
  • TABLE 142. BAYER AG: COMPANY SNAPSHOT
  • TABLE 143. BAYER AG: OPERATING SEGMENTS
  • TABLE 144. BAYER AG: PRODUCT PORTFOLIO
  • TABLE 145. BAYER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 146. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 147. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 148. GE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 149. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 150. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 151. PHILIPS HEALTHCARE: KEY EXECUTIVES
  • TABLE 152. PHILIPS HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 153. PHILIPS HEALTHCARE: OPERATING SEGMENTS
  • TABLE 154. PHILIPS HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 155. PHILIPS HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 156. SIEMENS HEALTHINEERS: KEY EXECUTIVES
  • TABLE 157. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
  • TABLE 158. SIEMENS HEALTHINEERS: OPERATING SEGMENTS
  • TABLE 159. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
  • TABLE 160. SIEMENS HEALTHINEERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 161. FUJIFILM HOLDINGS CORPORATION: KEY EXECUTIVES
  • TABLE 162. FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • TABLE 163. FUJIFILM HOLDINGS CORPORATION: OPERATING SEGMENTS
  • TABLE 164. FUJIFILM HOLDINGS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 165. FUJIFILM HOLDINGS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 166. CANON INC.: KEY EXECUTIVES
  • TABLE 167. CANON INC.: COMPANY SNAPSHOT
  • TABLE 168. CANON INC.: OPERATING SEGMENTS
  • TABLE 169. CANON INC.: PRODUCT PORTFOLIO
  • TABLE 170. CANON INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 171. PACSHEALTH, LLC: KEY EXECUTIVES
  • TABLE 172. PACSHEALTH, LLC: COMPANY SNAPSHOT
  • TABLE 173. PACSHEALTH, LLC: OPERATING SEGMENTS
  • TABLE 174. PACSHEALTH, LLC: PRODUCT PORTFOLIO
  • TABLE 175. PACSHEALTH, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 176. SECTRA AB: KEY EXECUTIVES
  • TABLE 177. SECTRA AB: COMPANY SNAPSHOT
  • TABLE 178. SECTRA AB: OPERATING SEGMENTS
  • TABLE 179. SECTRA AB: PRODUCT PORTFOLIO
  • TABLE 180. SECTRA AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 181. BRACCO IMAGING S.P.A.: KEY EXECUTIVES
  • TABLE 182. BRACCO IMAGING S.P.A.: COMPANY SNAPSHOT
  • TABLE 183. BRACCO IMAGING S.P.A.: OPERATING SEGMENTS
  • TABLE 184. BRACCO IMAGING S.P.A.: PRODUCT PORTFOLIO
  • TABLE 185. BRACCO IMAGING S.P.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 186. QAELUM N.V.: KEY EXECUTIVES
  • TABLE 187. QAELUM N.V.: COMPANY SNAPSHOT
  • TABLE 188. QAELUM N.V.: OPERATING SEGMENTS
  • TABLE 189. QAELUM N.V.: PRODUCT PORTFOLIO
  • TABLE 190. QAELUM N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 191. AGFA HEALTHCARE: KEY EXECUTIVES
  • TABLE 192. AGFA HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 193. AGFA HEALTHCARE: OPERATING SEGMENTS
  • TABLE 194. AGFA HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 195. AGFA HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL RADIATION DOSE MANAGEMENT MARKET SEGMENTATION
  • FIGURE 2. GLOBAL RADIATION DOSE MANAGEMENT MARKET
  • FIGURE 3. SEGMENTATION RADIATION DOSE MANAGEMENT MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN RADIATION DOSE MANAGEMENT MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALRADIATION DOSE MANAGEMENT MARKET
  • FIGURE 11. RADIATION DOSE MANAGEMENT MARKET SEGMENTATION, BY BY COMPONENT
  • FIGURE 12. RADIATION DOSE MANAGEMENT MARKET FOR SLOUTION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. RADIATION DOSE MANAGEMENT MARKET FOR SOFTWARE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. RADIATION DOSE MANAGEMENT MARKET SEGMENTATION, BY BY MOBILITY
  • FIGURE 15. RADIATION DOSE MANAGEMENT MARKET FOR COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. RADIATION DOSE MANAGEMENT MARKET FOR FLUOROSCOPY AND INTERVENTIONAL IMAGING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. RADIATION DOSE MANAGEMENT MARKET FOR RADIOGRAPHY AND MAMMOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. RADIATION DOSE MANAGEMENT MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 20. RADIATION DOSE MANAGEMENT MARKET FOR ONCOLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. RADIATION DOSE MANAGEMENT MARKET FOR CARDIOLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. RADIATION DOSE MANAGEMENT MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. RADIATION DOSE MANAGEMENT MARKET FOR OTHER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. RADIATION DOSE MANAGEMENT MARKET SEGMENTATION, BY BY END USER
  • FIGURE 25. RADIATION DOSE MANAGEMENT MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. RADIATION DOSE MANAGEMENT MARKET FOR SMALL HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. RADIATION DOSE MANAGEMENT MARKET FOR LARGE HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 28. RADIATION DOSE MANAGEMENT MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 29. RADIATION DOSE MANAGEMENT MARKET FOR OTHER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 30. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 31. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 32. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 33. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 34. COMPETITIVE DASHBOARD
  • FIGURE 35. COMPETITIVE HEATMAP: RADIATION DOSE MANAGEMENT MARKET
  • FIGURE 36. TOP PLAYER POSITIONING, 2024
  • FIGURE 37. BAYER AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. BAYER AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. BAYER AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. GE HEALTHCARE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. PHILIPS HEALTHCARE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. PHILIPS HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. PHILIPS HEALTHCARE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. SIEMENS HEALTHINEERS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. SIEMENS HEALTHINEERS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. SIEMENS HEALTHINEERS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. FUJIFILM HOLDINGS CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. FUJIFILM HOLDINGS CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. FUJIFILM HOLDINGS CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. CANON INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. CANON INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. CANON INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. PACSHEALTH, LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. PACSHEALTH, LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. PACSHEALTH, LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. SECTRA AB: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. SECTRA AB: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. SECTRA AB: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 61. BRACCO IMAGING S.P.A.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 62. BRACCO IMAGING S.P.A.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 63. BRACCO IMAGING S.P.A.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 64. QAELUM N.V.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 65. QAELUM N.V.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 66. QAELUM N.V.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 67. AGFA HEALTHCARE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 68. AGFA HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 69. AGFA HEALTHCARE: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Radiation Dose Management Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue